Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT02227056
Eligibility Criteria:
Inclusion Criteria:
1. Male and female.
2. Ages 4-18 years old.
3. No contraindications for Methylphenidate treatment such as hypersensitivity, cardiac disturbances unbalanced seizures etc'.
4. Informed consent given by their legal guardian.
5. Acquired brain injury
Exclusion Criteria:
1. Refusal to participate by either guardian or child.
2. No attentional disturbances in a computed screening exam: "TOVA".
3. Medical contraindications to treatment with Methylphenidate such as short QT syndrome.
4. Side effects due to treatment with Methylphenidate.
5. Under medical treatment of medications enhancing dopamine/ noradrenaline release such as Amantadine.
6. Unable to participate in tasks planned due to severe motor or cognitive disabilities.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
18 Years
Study:
NCT02227056
Study Brief:
Protocol Section:
NCT02227056